CDKN2A and benign neoplasm: For adipocytic tumors, the majority of the benign tumors had a negative expression of p16 (6/8; 75%) and CDK4 (8/8; 100%) while the majority of malignant and intermediate tumors had positive p16 (7/7; 100%) and CDK4 (6/7; 85.7%) expression.